Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer

  Free Subscription


21.10.2019

1 BMC Complement Altern Med
1 BMC Infect Dis
1 Brachytherapy
1 Bull Cancer
1 Cancer Immunol Immunother
1 Cancer Manag Res
1 Cancer Med
1 Carcinogenesis
1 DNA Cell Biol
2 Exp Ther Med
4 Gynecol Oncol
1 Int J Environ Res Public Health
1 J Cancer
1 J Obstet Gynaecol
1 Jpn J Clin Oncol
3 Medicine (Baltimore)
1 Oncol Lett
1 PeerJ
1 PLoS One
1 Radiol Med
1 Sci Rep
1 Small
1 Yeungnam Univ J Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Complement Altern Med

  1. ZHAO R, Shao X, Jia G, Huang Y, et al
    Anti-cervical carcinoma effect of Portulaca oleracea L. polysaccharides by oral administration on intestinal dendritic cells.
    BMC Complement Altern Med. 2019;19:161.
    PubMed     Text format     Abstract available


    BMC Infect Dis

  2. SURRIABRE P, Torrico A, Vargas T, Ugarte F, et al
    Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.
    BMC Infect Dis. 2019;19:842.
    PubMed     Text format     Abstract available


    Brachytherapy

  3. MAURO GP, Kleine RT, da Costa SCS, Carvalho HA, et al
    Vaginal cuff brachytherapy in the adjuvant setting for patients with high-risk early-stage cervical cancer.
    Brachytherapy. 2019 Oct 10. pii: S1538-4721(19)30442.
    PubMed     Text format     Abstract available


    Bull Cancer

  4. BELGLAIAA E, Mougin C
    [Cervical cancer: Current situation and management in Morocco].
    Bull Cancer. 2019 Oct 9. pii: S0007-4551(19)30337.
    PubMed     Text format     Abstract available


    Cancer Immunol Immunother

  5. HEEREN AM, van Luijk IF, Lakeman J, Pocorni N, et al
    Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer.
    Cancer Immunol Immunother. 2019 Oct 15. pii: 10.1007/s00262-019-02412.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  6. ZHANG H, Zhang J, Venkat PS, Gu C, et al
    Sanguinarine exhibits potent efficacy against cervical cancer cells through inhibiting the STAT3 pathway in vitro and in vivo.
    Cancer Manag Res. 2019;11:7557-7566.
    PubMed     Text format     Abstract available


    Cancer Med

  7. WANG SB, Liu JP, Lei KJ, Jia YM, et al
    The volume of (99m) Tc sulfur colloid SPET-defined active bone marrow can predict grade 3 or higher acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy.
    Cancer Med. 2019 Oct 16. doi: 10.1002/cam4.2601.
    PubMed     Text format     Abstract available


    Carcinogenesis

  8. BAI X, Wang W, Zhao P, Wen J, et al
    LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression.
    Carcinogenesis. 2019 Oct 12. pii: 5586248. doi: 10.1093.
    PubMed     Text format     Abstract available


    DNA Cell Biol

  9. OVED JH, Graul A, Burger RA, Schwartz LE, et al
    Exceptional Response to Nivolumab in a 13-Year-Old Female with Metastatic HPV-Negative Cervical Carcinoma.
    DNA Cell Biol. 2019;38:1143-1146.
    PubMed     Text format     Abstract available


    Exp Ther Med

  10. WANG Y, Chen Y, Chen X, Liang Y, et al
    Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy.
    Exp Ther Med. 2019;18:3365-3374.
    PubMed     Text format     Abstract available

  11. MENG F, Ou J, Liu J, Li X, et al
    MicroRNA-877 is downregulated in cervical cancer and directly targets MACC1 to inhibit cell proliferation and invasion.
    Exp Ther Med. 2019;18:3650-3658.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  12. LI W, Meng Y, Wang Y, Cheng X, et al
    Association of age and viral factors with high-risk HPV persistence: A retrospective follow-up study.
    Gynecol Oncol. 2019 Jun 24. pii: S0090-8258(19)31270.
    PubMed     Text format     Abstract available

  13. DOTTINO JA, He W, Sun CC, Zhao H, et al
    Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes.
    Gynecol Oncol. 2019 Jun 14. pii: S0090-8258(19)31280.
    PubMed     Text format     Abstract available

  14. DICK S, Kremer WW, De Strooper LMA, Lissenberg-Witte BI, et al
    Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis.
    Gynecol Oncol. 2019 Jun 7. pii: S0090-8258(19)31279.
    PubMed     Text format     Abstract available

  15. VAN KOL KGG, Vergeldt TFM, Bekkers RLM
    Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates.
    Gynecol Oncol. 2019 Oct 9. pii: S0090-8258(19)31546.
    PubMed     Text format     Abstract available


    Int J Environ Res Public Health

  16. LIU CH, Lee YC, Lin JC, Chan IS, et al
    Radical Hysterectomy After Neoadjuvant Chemotherapy for Locally Bulky-Size Cervical Cancer: A Retrospective Comparative Analysis between the Robotic and Abdominal Approaches.
    Int J Environ Res Public Health. 2019;16.
    PubMed     Text format     Abstract available


    J Cancer

  17. YANG Z, Gu Q, Wang Y, Liu B, et al
    Heavy-Ion Carbon Radiation Regulates Long Non-Coding RNAs in Cervical Cancer HeLa Cells.
    J Cancer. 2019;10:5022-5030.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol

  18. GULSEREN V, Kocaer M, Cakir I, Ozdemir IA, et al
    Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    J Obstet Gynaecol. 2019 Oct 12:1-6. doi: 10.1080/01443615.2019.1652888.
    PubMed     Text format     Abstract available


    Jpn J Clin Oncol

  19. MURAKAMI N, Isohashi F, Hasumi Y, Kasamatsu T, et al
    Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).
    Jpn J Clin Oncol. 2019;49:881-885.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  20. TIAN S, Yang X, Zhang L, Zhao J, et al
    Polymorphic variants conferring genetic risk to cervical lesions support GSTs as important associated loci.
    Medicine (Baltimore). 2019;98:e17487.
    PubMed     Text format     Abstract available

  21. JIN R, Qian H, Zhang Y, Yuan D, et al
    The prevalence and genotype distribution of human papillomaviruses among women in Taizhou, China.
    Medicine (Baltimore). 2019;98:e17293.
    PubMed     Text format     Abstract available

  22. YAN W, Si L, Ding Y, Qiu S, et al
    Neoadjuvant chemotherapy does not improve the prognosis and lymph node metastasis rate of locally advanced cervical squamous cell carcinoma: A retrospective cohort study in China.
    Medicine (Baltimore). 2019;98:e17234.
    PubMed     Text format     Abstract available


    Oncol Lett

  23. DING TT, Ma H, Feng JH
    A three-gene novel predictor for improving the prognosis of cervical cancer.
    Oncol Lett. 2019;18:4907-4915.
    PubMed     Text format     Abstract available


    PeerJ

  24. CHEN R, Gong Y, Zou D, Wang L, et al
    Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer.
    PeerJ. 2019;7:e7804.
    PubMed     Text format     Abstract available


    PLoS One


  25. Retraction: MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1.
    PLoS One. 2019;14:e0224167.
    PubMed     Text format    


    Radiol Med

  26. CIOLINA M, Vinci V, Villani L, Gigli S, et al
    Texture analysis versus conventional MRI prognostic factors in predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced cancer of the uterine cervix.
    Radiol Med. 2019;124:955-964.
    PubMed     Text format     Abstract available


    Sci Rep

  27. JERMY BR, Alomari M, Ravinayagam V, Almofty SA, et al
    SPIONs/3D SiSBA-16 based Multifunctional Nanoformulation for target specific cisplatin release in colon and cervical cancer cell lines.
    Sci Rep. 2019;9:14523.
    PubMed     Text format     Abstract available


    Small

  28. QIAN Q, Shi L, Gao X, Ma Y, et al
    A Paclitaxel-Based Mucoadhesive Nanogel with Multivalent Interactions for Cervical Cancer Therapy.
    Small. 2019 Oct 16:e1903208. doi: 10.1002/smll.201903208.
    PubMed     Text format     Abstract available


    Yeungnam Univ J Med

  29. OH J, Seol KH, Choi YS, Lee JW, et al
    Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Yeungnam Univ J Med. 2019;36:115-123.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: